An introduction to telomeres and telomeraseBIBBY, Michael C.Molecular biotechnology. 2003, Vol 24, Num 3, pp 295-301, issn 1073-6085, 7 p.Article

Application of biological effective dose (BED) to estimate the duration of symptomatic relief and repopulation dose equivalent in palliative radiotherapy and chemotherapyJONES, Bleddyn; COMINOS, Matilda; DALE, Roger G et al.International journal of radiation oncology, biology, physics. 2003, Vol 55, Num 3, pp 736-742, issn 0360-3016, 7 p.Article

The effect of repetitive magnetic stimulation on the tumor developmentYAMAGUCHI, Sachiko; OGIUE-IKEDA, Mari; SEKINO, Masaki et al.IEEE transactions on magnetics. 2004, Vol 40, Num 4, pp 3021-3023, issn 0018-9464, 3 p., 2Conference Paper

New cytosine derivatives as inhibitors of DNA methylationPLITTA, Beata; ADAMSKA, Ewelina; GIEL-PIETRASZUK, Malgorzata et al.European journal of medicinal chemistry. 2012, Vol 55, pp 243-254, issn 0223-5234, 12 p.Article

Medical applications of magnetic nanoparticlesALEXIOU, C; JURGONS, R; SELIGER, C et al.Journal of nanoscience and nanotechnology (Print). 2006, Vol 6, Num 9-10, pp 2762-2768, issn 1533-4880, 7 p.Article

Interfering with hemostatic system components: Possible new approaches to antiangiogenic therapyWOJTUKIEWICZ, Marek Z; SIERKO, Ewa; ZACHARSKI, Leo R et al.Seminars in thrombosis and hemostasis. 2004, Vol 30, Num 1, pp 145-156, issn 0094-6176, 12 p.Article

Nature's best weapons to fight cancer. Revival of human monoclonal IgM antibodiesVOLLMERS, H. Peter; BRÄNDLEIN, Stephanie.Human antibodies. 2002, Vol 11, Num 4, pp 131-142, issn 1093-2607, 12 p.Article

Apoptosis and melanoma chemoresistanceSOENGAS, Maria S; LOWE, Scott W.Oncogene (Basingstoke). 2003, Vol 22, Num 20, pp 3138-3151, issn 0950-9232, 14 p.Article

Optimal dosing of cancer chemotherapy using model predictive control and moving horizon state/parameter estimationTAO CHEN; KIRKBY, Norman F; JENA, Raj et al.Computer methods and programs in biomedicine (Print). 2012, Vol 108, Num 3, pp 973-983, issn 0169-2607, 11 p.Article

Synthesis and biological evaluation of imidazo[4,5-b]pyridine and 4-heteroaryl-pyrimidine derivatives as anti-cancer agentsLUKASIK, Pawel M; ELABAR, Sherifa; LAM, Frankie et al.European journal of medicinal chemistry. 2012, Vol 57, pp 311-322, issn 0223-5234, 12 p.Article

Biological applications of LbL multilayer capsules: From drug delivery to sensingDEL MERCATO, Loretta Laureana; FERRARO, Marzia Maria; BALDASSARRE, Francesca et al.Advances in colloid and interface science (Print). 2014, Vol 207, pp 139-154, issn 0001-8686, 16 p.Article

Manageable cytotoxicity of nanocapsules immobilizing D-amino acid oxidase via exogenous administration of nontoxic prodrugYANG ZHAO; YINGCHUN ZHU; JINGKE FU et al.Applied surface science. 2014, Vol 293, pp 109-115, issn 0169-4332, 7 p.Article

Plant-derived epigenetic modulators for cancer treatment and preventionSCHNEKENBURGER, Michael; DICATO, Mario; DIEDERICH, Marc et al.Biotechnology advances. 2014, Vol 32, Num 6, pp 1123-1132, issn 0734-9750, 10 p.Conference Paper

PAMAM dendrimer-coated iron oxide nanoparticles: synthesis and characterization of different generationsKHODADUST, Rouhollah; UNSOY, Gozde; YALCIN, Serap et al.Journal of nanoparticle research. 2013, Vol 15, Num 3, issn 1388-0764, 1488.1-1488.13Article

Phase 1, open-label study of MEDI-547 in patients with relapsed or refractory solid tumorsANNUNZIATA, Christina M; KOHN, Elise C; LORUSSO, Patricia et al.Investigational new drugs. 2013, Vol 31, Num 1, pp 77-84, issn 0167-6997, 8 p.Article

Tumor stroma as targets for cancer therapyJING ZHANG; JINSONG LIU.Pharmacology & therapeutics (Oxford). 2013, Vol 137, Num 2, pp 200-215, issn 0163-7258, 16 p.Article

Application of nuclear track detectors as sensors for photoneutrons generated by medical acceleratorsSZYDLOWSKI, A; JASKOLA, M; KUK, M et al.Radiation measurements. 2013, Vol 50, pp 74-77, issn 1350-4487, 4 p.Conference Paper

Discovery and SAR of orally efficacious tetrahydropyridopyridazinone PARP inhibitors for the treatment of cancerZHU, Gui-Dong; JIANCHUN GONG; OLSON, Amanda M et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 15, pp 4635-4645, issn 0968-0896, 11 p.Article

Inappropriate gene expression in human cancer and its far-reaching biological and clinical significanceTARIN, David.Cancer metastasis reviews. 2012, Vol 31, Num 1-2, pp 21-39, issn 0167-7659, 19 p.Article

The endoperoxide ascaridol shows strong differential cytotoxicity in nucleotide excision repair-deficient cellsABBASI, Rashda; EFFERTH, Thomas; KUHMANN, Christine et al.Toxicology and applied pharmacology. 2012, Vol 259, Num 3, pp 302-310, issn 0041-008X, 9 p.Article

The phosphoinositide 3-kinase/mammalian target of rapamycin inhibitor NVP-BEZ235 is effective in inhibiting regrowth of tumour cells after cytotoxic therapyHERNLUND, Emma; HÄGG OLOFSSON, Maria; DE MILITO, Angelo et al.European journal of cancer (1990). 2012, Vol 48, Num 3, pp 396-406, issn 0959-8049, 11 p.Article

Nanoparticle and targeted systems for cancer therapyBRANNON-PEPPAS, Lisa; BLANCHETTE, James O.Advanced drug delivery reviews. 2012, Vol 64, pp 206-212, issn 0169-409X, 7 p., SUPArticle

Can non-viral technologies knockdown the barriers to siRNA delivery and achieve the next generation of cancer therapeutics?JIANFENG GUO; BOURRE, Ludovic; SODEN, Declan M et al.Biotechnology advances. 2011, Vol 29, Num 4, pp 402-417, issn 0734-9750, 16 p.Article

Inhibition of tumor angiogenesis in lung cancer by T4 phage surface displaying mVEGFR2 vaccineSHUNXIANG REN; FENGYU; SHUGUANG ZUO et al.Vaccine. 2011, Vol 29, Num 34, pp 5802-5811, issn 0264-410X, 10 p.Article

Novel ARF/p53-independent senescence pathways in cancer repressionCHAN, Chia-Hsin; YUAN GAO; MOTEN, Asad et al.Journal of molecular medicine (Berlin. Print). 2011, Vol 89, Num 9, pp 857-867, issn 0946-2716, 11 p.Article